Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified. more
| Time Frame | OZEM | S&P500 |
|---|---|---|
| 1-Week Return | -1.09% | 0.5% |
| 1-Month Return | 1.92% | 3.86% |
| 3-Month Return | 5.99% | 1.92% |
| 6-Month Return | 0.14% | 12.03% |
| 1-Year Return | 29.77% | 18.56% |
| 3-Year Return | 31.81% | 73.83% |
| Time Frame | OZEM | S&P500 |
|---|---|---|
| 1-Week Return | -43.53% | 29.70% |
| 1-Month Return | 26.03% | 58.53% |
| 3-Month Return | 26.61% | 8.02% |
| 6-Month Return | 0.28% | 25.90% |
| 1-Year Return | 29.77% | 18.56% |
| 3-Year Return | 9.64% | 20.24% |
| Stock name | Ticker | Weight |
|---|---|---|
Eli Lilly & Co | LLY | 12.01% |
Novo Nordisk A/S | NVO | 11.93% |
Pfizer Inc | PFE | 7.17% |
CSPC Pharmaceutical Group Ltd | 1093.HK | 7.01% |
Hanmi Pharm Co Ltd | 128940.KS | 4.88% |
Viking Therapeutics Inc | VKTX | 4.67% |
Amgen Inc | AMGN | 4.44% |
Kailera Therapeutics Inc | KLRA | 4.42% |
Zealand Pharma A/S | ZEAL.CO | 4.16% |
Chugai Pharmaceutical Co Ltd | 4519.T | 4.12% |
Ascletis Pharma Inc | 1672.HK | 3.87% |
AstraZeneca PLC | AZN | 3.18% |
Roche Holding AG | ROP.SW | 3.14% |
MBX Biosciences Inc | MBX | 3.09% |
Innovent Biologics Inc | 1801.HK | 3.08% |
Hansoh Pharmaceutical Group Co Ltd | 3692.HK | 3.04% |
Structure Therapeutics Inc | GPCR | 2.61% |
United Laboratories International Holdings Ltd/The | 3933.HK | 2.57% |
Gubra A/S | GUBRA.CO | 2.23% |
Jiangsu Hengrui Pharmaceuticals Co Ltd | 1276.HK | 2.06% |
Gilead Sciences Inc | GILD | 1.93% |
Rhythm Pharmaceuticals Inc | RYTM | 1.52% |
Shionogi & Co Ltd | 4507.T | 1.25% |
First American Government Obligations Fund 12/01/2031 | FGXXX | 0.95% |
Wave Life Sciences Inc | WVE | 0.73% |
Cash & Other | Cash...Other | 0.3% |
JAPANESE YEN | JPY | 0.03% |
SWISS FRANC | CHF | -0.41% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
Roundhill Glp-1 & Weight Loss ETF (OZEM) share price today is $32.84.
Yes, Indians can buy shares of Roundhill Glp-1 & Weight Loss ETF (OZEM) on Vested. To buy OZEM from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Roundhill Glp-1 & Weight Loss ETF (OZEM) on Vested. You can start investing in Roundhill Glp-1 & Weight Loss ETF (OZEM) with a minimum investment of $1.
The 52-week high price of Roundhill Glp-1 & Weight Loss ETF (OZEM) is $37.15. The 52-week low price of Roundhill Glp-1 & Weight Loss ETF (OZEM) is $25.36.
The stock symbol (or ticker) of Roundhill Glp-1 & Weight Loss ETF is OZEM.
Yes, you can setup SIP in Roundhill Glp-1 & Weight Loss ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of OZEM on the Vested app.
The expense ratio of Roundhill Glp-1 & Weight Loss ETF (OZEM) is 0.59%.
Link copied